C. K. Svensson

发表

Comparison of chromatographic and spectrophotometric analysis of indocyanine green in plasma following administration of multiple doses to humans.

E. Middleton, D. Edwards, P. M. Mauriello, 1982, Journal of pharmaceutical sciences.

Effect of Arylhydroxylamine Metabolites of Sulfamethoxazole and Dapsone on Stress Signal Expression in Human Keratinocytes

F. Khan, A. Gaspari, C. K. Svensson, 2007, Journal of Pharmacology and Experimental Therapeutics.

Attenuation of Response to Repeated Drug Administration: A Proposal for Differentiating Tachyphylaxis and Tolerance

C. K. Svensson, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Clinical Pharmacokinetics of Pethidine: 1982

D. Edwards, C. K. Svensson, D. Lalka, 1982, Clinical pharmacokinetics.

Phenotypic and Genotypic Characterization of N -Acetylation

D. Hein, C. K. Svensson, C. Svensson, 2005 .

Effect of food on hepatic blood flow: Implications in the “food effect” phenomenon

E. Middleton, R. Lanc, D. Edwards, 1983, Clinical pharmacology and therapeutics.

Biotransformation of Drugs in Human Skin

C. K. Svensson, C. Svensson, 2009, Drug Metabolism and Disposition.

Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype.

R. MacArthur, M. Doll, D. Hein, 2000, Pharmacogenetics.

Immune response to xenobiotics in the skin: from contact sensitivity to drug allergy

F. Khan, A. Gaspari, S. Roychowdhury, 2006, Expert opinion on drug metabolism & toxicology.

Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts.

M. Doll, D. Hein, S. Roychowdhury, 2006, Toxicology and applied pharmacology.

Vancomycin pharmacokinetics in burn patients and intravenous drug abusers

M. Rybak, L. Warbasse, C. K. Svensson, 1990, Antimicrobial Agents and Chemotherapy.

Commentary: Drug hypersensitivity—Where do we stand?

C. K. Svensson, 2006, The AAPS Journal.

Clinical Pharmacokinetics of Nicotine

C. K. Svensson, C. Svensson, 1987, Clinical pharmacokinetics.

Beta-glucuronidase activity in patients infected with HIV.

R. MacArthur, L. Crane, C. K. Svensson, 2003, AIDS.

ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE

S. Roychowdhury, C. K. Svensson, P. Vyas, 2006, Drug Metabolism and Disposition.

Cellular distribution of N-acetyltransferase activity in the rat small intestine.

J. Ware, T. Reilly, C. K. Svensson, 1998, Biochemical pharmacology.

Effect of streptolysin-O-on rat hepatic acetyl coenzyme-A: arylamine N-acetyltransferase and cytochrome P-450 2B 1/2 activities ex vivo.

C. K. Svensson, R. Drobitch, P. Divakaruni, 1998, Immunopharmacology and immunotoxicology.

Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity.

C. K. Svensson, D. Lalka, R. Heintz, 1986, Journal of pharmaceutical sciences.

Effect of carbohydrates on estimated hepatic blood flow

E. Middleton, P. M. Mauriello, C. K. Svensson, 1984, Clinical pharmacology and therapeutics.

Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.

P. Woster, S. Roychowdhury, C. K. Svensson, 2005, Biochemical pharmacology.

Acetylator Phenotype and Genotype in HIV‐Infected Patients with and without Sulfonamide Hypersensitivity

R. MacArthur, M. Doll, D. Hein, 2002, Journal of clinical pharmacology.

Acetyl CoA:arylamine N-acetyltransferase activity in rat hepatocytes cultured on different extracellular matrices.

W. Lindblad, M. Doll, D. Hein, 1997, Toxicology in vitro : an international journal published in association with BIBRA.

Disposition of Procainamide in Patients with Chronic Congestive Heart Failure Receiving Medical Therapy

J. Ware, M. Rudis, B. Zarowitz, 1996, Journal of clinical pharmacology.

Effect of glutathione depletion on the in vivo inhibition of drug metabolism by agents forming an inactive cytochrome P-450 Fe(II):metabolite complex. Studies with amiodarone and troleandomycin.

C. K. Svensson, R. Drobitch, K. A. Kloss, 1991, Journal of pharmaceutical sciences.

Effect of amiodarone on the disposition of acetaminophen in the rat.

C. K. Svensson, M. Chong, 1989, Journal of pharmaceutical sciences.

Effect of amiodarone on the disposition of procainamide in the rat.

C. K. Svensson, P. Knowlton, L. L. Liu, 1988, Journal of pharmaceutical sciences.

Relationship between antipyrine elimination rate constant, clearance and volume of distribution in the rat

C. K. Svensson, 1987, The Journal of pharmacy and pharmacology.

Disposition of Sulfamethazine and N-Acetylsulfamethazine in the Rat

H. Zaher, C. K. Svensson, M. Tomilo, 1991, Pharmaceutical Research.

Effect of the Immunomodulator Tilorone on the in Vivo Acetylation of Procainamide in the Rat

C. K. Svensson, P. Knowlton, 1989, Pharmaceutical Research.

Immunomodulation and drug acetylation: influence of the immunomodulator tilorone on hepatic, renal and blood N-acetyltransferase activity and on hepatic cytosolic acetyl coenzyme A content.

C. K. Svensson, M. Tomilo, R. Drobitch, 1992, Biochemical pharmacology.

Effects of chloroquine and primaquine on rat liver cytosolic N-acetyltransferase activity.

C. K. Svensson, M. Tomilo, R. Drobitch, 1991, Biochemical pharmacology.

Cutaneous drug reactions.

E. Cowen, A. Gaspari, C. K. Svensson, 2001, Pharmacological reviews.

Effect of pro-inflammatory cytokines on the toxicity of the arylhydroxylamine metabolites of sulphamethoxazole and dapsone in normal human keratinocytes.

P. Woster, F. Khan, S. Roychowdhury, 2006, Toxicology.

A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.

P. Woster, L. Lash, M. Doll, 2000, The Journal of investigative dermatology.

Free Drug Concentration Monitoring in Clinical Practice

M. Woodruff, C. K. Svensson, D. Lalka, 1986 .

Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450

J. Goldstein, E. Schuetz, R. Hines, 2006, Journal of Pharmacology and Experimental Therapeutics.

Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone.

P. Woster, T. Reilly, C. K. Svensson, 1998, Biochemical pharmacology.

Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1.

C. K. Svensson, C. Vage, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Characterization of the Formation and Localization of Sulfamethoxazole and Dapsone-Associated Drug-Protein Adducts in Human Epidermal Keratinocytes

A. Gaspari, T. Reilly, S. Roychowdhury, 2005, Journal of Pharmacology and Experimental Therapeutics.

Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?

P. Woster, R. MacArthur, T. Reilly, 1999, The Journal of pharmacology and experimental therapeutics.

Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.

P. Woster, T. Reilly, C. K. Svensson, 1999, The Journal of pharmacology and experimental therapeutics.

Inhibition of Drug Metabolism by Quinolone Antibiotics

S. Bowles, M. Rybak, D. Edwards, 1988, Clinical pharmacokinetics.

Free drug concentration monitoring in clinical practice. Rationale and current status.

M. Woodruff, C. K. Svensson, D. Lalka, 1986, Clinical pharmacokinetics.

Therapeutic Drug Monitoring in Saliva

C. K. Svensson, R. Drobitch, C. Svensson, 1992, Clinical pharmacokinetics.

Effects of hydralazine, nitroglycerin, and food on estimated hepatic blood flow

E. Middleton, C. K. Svensson, David Lalka, 1985, Clinical pharmacology and therapeutics.

Is blood sampling for determination of antipyrine pharmacokinetics in healthy volunteers ethically justified?

C. K. Svensson, 1988, Clinical pharmacology and therapeutics.

Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin

S. Roychowdhury, C. K. Svensson, C. Svensson, 2005, The AAPS Journal.

Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.

P. Woster, C. K. Svensson, C. Vage, 1994, Toxicology and applied pharmacology.

Maintaining Pharmacy Education’s Research Focus as the Academy Expands

R. Brueggemeier, M. Speedie, C. K. Svensson, 2012, American Journal of Pharmaceutical Education.

Are We Producing Innovators and Leaders or Change Resisters and Followers?

R. Brueggemeier, M. Speedie, C. K. Svensson, 2012, American Journal of Pharmaceutical Education.

Formation and Uptake of Arylhydroxylamine-Haptenated Proteins in Human Dendritic Cells

S. Roychowdhury, C. K. Svensson, P. Vyas, 2007, Drug Metabolism and Disposition.

DMD # 13680 1 Formation and Uptake of Arylhydroxylamine-Haptenated Proteins in Human Dendritic Cells

S. Roychowdhury, C. K. Svensson, P. Vyas, 2007 .

Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases

David E. Williams, S. B. Koukouritaki, R. Hines, 2006, Journal of Pharmacology and Experimental Therapeutics.

Pharmacogenomics of acetaminophen in pediatric populations: a moving target

G. Knipp, Wanqing Liu, C. K. Svensson, 2014, Front. Genet..

Do arylhydroxylamine metabolites mediate idiosyncratic reactions associated with sulfonamides?

C. K. Svensson, 2003, Chemical research in toxicology.

Arylacetamide deacetylase activity towards monoacetyldapsone. Species comparison, factors that influence activity, and comparison with 2-acetylaminofluorene and p-nitrophenyl acetate hydrolysis.

C. K. Svensson, C. V. Preuss, C. Svensson, 1996, Biochemical pharmacology.

Enhanced Xenobiotic-Induced Hepatotoxicity and Kupffer Cell Activation by Restraint-Induced Stress

F. Khan, C. K. Svensson, S. Panuganti, 2006, Journal of Pharmacology and Experimental Therapeutics.

Effect of Amiodarone and Desethylamiodarone on the Pharmacokinetics of Antipyrine in the Rat

C. K. Svensson, P. Knowlton, Li-Ling Liu, 1987, Pharmaceutical Research.

Effect of the immunomodulator tilorone on antipyrine disposition in the rat.

C. K. Svensson, 1986, Journal of pharmaceutical sciences.

What Should Constitute an Acceptable Advanced Pharmacy Practice Experience?

C. K. Svensson, 2016, American Journal of Pharmaceutical Education.

Assessing quality in pharmacy education in an era of rapid expansion: response to Maine and Vlasses.

N. G. Popovich, C. K. Svensson, D. Sullivan, 2013, Journal of the American Pharmacists Association : JAPhA.

Effect of single and short-term multiple exposure to honeybee venom on the disposition of antipyrine in the rat

C. K. Svensson, 1987 .

Representation of American blacks in clinical trials of new drugs.

C. K. Svensson, C. Svensson, 1989, JAMA.

Inhibition of N‐Acetylation of Procainamide and Renal Clearance of N‐Acetylprocainamide by Para‐Aminobenzoic Acid in Humans

J. Ware, M. Rudis, B. Zarowitz, 1995, Journal of clinical pharmacology.

Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine.

J. Ware, C. K. Svensson, 1996, Biochemical pharmacology.

Dextromethorphan Pretreatment Induces Antipyrine Clearance in the Rat

J. Ware, C. K. Svensson, 1988, Pharmaceutical Research.

Ethical Considerations in the Conduct of Clinical Pharmacokinetic Studies

C. K. Svensson, C K Svensson, 1989, Clinical pharmacokinetics.